NR3C2 and hydrops fetalis: Accordingly, we analysed, by immunoblot, lymphocyte GRK2 levels in human HF patients treated with spironolactone and compared these levels to a cohort of similarly diseased patients where the MR-antagonist was not used (Supplementary Table 1).